Actuate Therapeutics, Inc. (ACTU)
0.3202
-0.01
(-2.08%)
USD |
NASDAQ |
Nov 06, 10:16
Actuate Therapeutics Market Cap : 7.689M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 7.852M |
| November 04, 2026 | 8.883M |
| November 03, 2026 | 8.405M |
| November 02, 2026 | 8.213M |
| October 30, 2026 | 8.047M |
| October 29, 2026 | 8.909M |
| October 28, 2026 | 9.204M |
| October 27, 2026 | 9.593M |
| October 26, 2026 | 12.68M |
| October 23, 2026 | 11.41M |
| October 22, 2026 | 12.40M |
| October 21, 2026 | 13.50M |
| October 20, 2026 | 14.79M |
| October 19, 2026 | 14.38M |
| October 16, 2026 | 14.53M |
| October 15, 2026 | 12.00M |
| October 14, 2026 | 10.43M |
| October 13, 2026 | 11.20M |
| October 12, 2026 | 15.46M |
| October 09, 2026 | 14.65M |
| October 08, 2026 | 16.31M |
| October 07, 2026 | 17.39M |
| October 06, 2026 | 19.49M |
| October 05, 2026 | 21.01M |
| October 02, 2026 | 19.67M |
| Date | Value |
|---|---|
| October 01, 2026 | 21.35M |
| September 30, 2026 | 18.72M |
| September 29, 2026 | 16.47M |
| September 28, 2026 | 17.68M |
| September 25, 2026 | 16.33M |
| September 24, 2026 | 14.89M |
| September 23, 2026 | 17.57M |
| September 22, 2026 | 19.39M |
| September 21, 2026 | 21.79M |
| September 18, 2026 | 23.56M |
| September 17, 2026 | 23.90M |
| September 16, 2026 | 23.95M |
| September 15, 2026 | 23.62M |
| September 14, 2026 | 24.73M |
| September 11, 2026 | 25.69M |
| September 10, 2026 | 27.62M |
| September 09, 2026 | 30.26M |
| September 08, 2026 | 32.90M |
| September 04, 2026 | 35.54M |
| September 03, 2026 | 32.90M |
| September 02, 2026 | 31.22M |
| September 01, 2026 | 36.98M |
| August 31, 2026 | 36.50M |
| August 28, 2026 | 39.74M |
| August 27, 2026 | 40.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 508.30B |
| ACADIA Pharmaceuticals, Inc. | 3.599B |
| Alnylam Pharmaceuticals, Inc. | 21.22B |
| Anika Therapeutics, Inc. | 224.83M |
| Savara, Inc. | 953.05M |
Market Cap Related Metrics
| Price to Book Value | 7.774 |
| Price | 0.3202 |
| Earnings Yield | -278.4% |